Exenatide + Insulin

Phase 2/3Completed
0 views this week 0 watching💤 Quiet
Interest: 38/100
38
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Stress Hyperglycemia

Conditions

Stress Hyperglycemia

Trial Timeline

Jan 1, 2015 → Dec 1, 2016

About Exenatide + Insulin

Exenatide + Insulin is a phase 2/3 stage product being developed by Eli Lilly for Stress Hyperglycemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01969149. Target conditions include Stress Hyperglycemia.

What happened to similar drugs?

8 of 20 similar drugs in Stress Hyperglycemia were approved

Approved (8) Terminated (1) Active (12)
solifenacinAstellas PharmaApproved
duloxetine HClEli LillyApproved
Minocycline + PlaceboJohnson & JohnsonApproved
Placebo + sertralineJohnson & JohnsonApproved
Adjunctive asenapineMerckApproved
ZiprasidonePfizerApproved

Hype Score Breakdown

Clinical
15
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT02432976Phase 2/3Completed
NCT01969149Phase 2/3Completed
NCT00099333Phase 2Completed

Competing Products

20 competing products in Stress Hyperglycemia

See all competitors
ProductCompanyStageHype Score
Duloxetine + placeboEli LillyPhase 2
35
agenT-797MiNK TherapeuticsPhase 1
19
Thermal stress and performance without a pre-cooling protocolPetros PharmaceuticalsPre-clinical
16
solifenacinAstellas PharmaApproved
43
SivelestatEli LillyPhase 1/2
32
Duloxetine + PlaceboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40
Duloxetine + PlaceboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40
Duloxetine hydrochlorideEli LillyPhase 3
36
DuloxetineEli LillyPhase 3
40
duloxetine + PlaceboEli LillyPhase 2
35
DuloxetineEli LillyPhase 3
40
duloxetine HClEli LillyApproved
43
Orforglipron + PlaceboEli LillyPhase 3
47
Duloxetine hydrochloride + placeboEli LillyApproved
43
Duloxetine + PlaceboEli LillyPhase 3
40
duloxetine + placeboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40
Duloxetine Hydrochloride + placeboEli LillyPhase 3
40